The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Tag Archives: ethica Clinical Research

Trends Update — Personalized Medicine: Montreal CRO ethica Licenses Artificial Intelligence Data Analysis Product for Stratification

B&W_DNA_sequenceethica Clinical Research acquired a worldwide exclusive license to Matrix Pharma’s  artificial intelligence (AI) data analysis platform.  Neither the form of consideration nor payment structure (up-front vs royalty etc.) was disclosed, but the deal is “valued at CAD1.25 Million.”  The companies say the AI can:

“extract interdependencies, correlations, and predictive models from complex data sets that conventional statistical tools are unable to detect.”

In other words, it’s an approach designed for stratification of clinical trial data to identify personalized subgroups for whom a drug may be particularly effective.

ethica says the product, which will be marketed as “eidyia™” (pronounced “idea”)

“has already yielded successful results in a series of clinical applications such as identifying biomarkers, optimizing the predictive power of biomarkers, identifying responder/non-responder indices, genotype-phenotype linkages, elaborating models for early diagnosis, and for classifying participants in Phase II clinical trials for the optimization of Phase III clinical trials.”

I don’t know if  “eidyia” is (or isn’t) the best platform for these tasks; but I am convinced that in many cases, the ability to stratify patient populations will be key to demonstrating the effectiveness of new drugs and winning approval and reimbursement.

Bookmark and Share

Follow

Get every new post delivered to your Inbox.

Join 126 other followers